About DynaSci
DynaSci’s founders have been actively involved in the pharmaceutical industry since 1923 – a generational affair, each succession has built on the collective experience of their predecessors, to further develop their understanding of the sector.
Following the successful sale of MN Pharmaceuticals to Amgen in 2012, a series of carve-outs laid the building blocks of what was to become DynaSci. The Family still retains assets in some of the oldest industrial sectors in Turkey.
DynaSci is made up of seasoned managers both from within, and out of the Pharmaceutical Industry. The new operating model is based on the shortcomings of a conventional industry, creating a re-invented healthcare company.
DynaSci creates; easy to manufacture, patent protected, pre-mix formulations, with clinical studies, focused on products and indications with a large global potential.
Why Are We Different?
Big Pharma and other pharmaceutical companies’ business models require thousands of employees with large amounts of CAPEX and OPEX whereas we don’t
As a virtual organization, we only employ strategic personnel with vital roles who can manage the outsourcing of the necessary tasks to the best organizations in their respective fields
Everything from R&D activities to active ingredient manufacturing and FDF (Finished Dosage Form) manufacturing is outsourced
The R&D related information obtained from the outsourced organizations, including formulation development, are integrated in DynaSci; and the formulations ready to be tested are directed to CROs which conduct pre-clinical and clinical studies.
Pharma based experience we had with prescription products, helped us create unique products that can be in powder or liquid form.
The manufacturing process of the product is as simple as it gets, and the technology is easily transferable to an existing manufacturing facility.
All of the excipients used in the products are food grade so there are no regulatory issues. Furthermore, we don’t use any organic solvents such as ethanol. In addition, the technology can be applied to oils and solid extracts as well.
A Unique Science Based Approach
Most companies operating in the Nutraceutical F&B field do not conduct sufficient scientific studies to support their claims on the benefits of their products; therefore, the actual effects of the active compounds is a mystery.
At DynaSci, we follow every step a pharma company does: first, we make dozens of formulations; secondly, we do cell studies; thirdly, we test the compounds on animals; and finally, we conduct clinical trials to have cleat cut results about the specific blood concentration of a compound.
